Advertisement

Topics

PIN Pharma Announces Initiation of its First Phase 1 Study

10:54 EST 15 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
PIN Pharma today announced the initiation of a Phase 1 clinical trial for its novel immune-modulator, PIN-2. This first-in-human, proof-of-concept study is being conducted in oncology patients with solid tumors by PIN P...

Other Sources for this Article

PIN Pharma, Inc.
Mark Smith, CFO, 212-543-2583
msmith@pinpharma.com
or
Colin Bier, CEO, 212-543-2583
cbier@pinpharma.com

NEXT ARTICLE

More From BioPortfolio on "PIN Pharma Announces Initiation of its First Phase 1 Study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...